Patient Care and Research

ASTRO-MRA Early Career Investigator Award in Radiation Oncology

Applications for the 2018 ASTRO-MRA Early Career Investigator Award in Radiation Oncology are now open. Applicants must submit an eligibility checklist by October 29, 2018 (see below for details). Final applications will be due on November 9, 2018.

What is the goal of the ASTRO-MRA Early Career Investigator Award?

Research in radiation oncology has led to advancements in technology and therapy that have improved patient outcomes and care. ASTRO is pleased to partner with the Melanoma Research Alliance (MRA) to offer a special opportunity to support research in radiation oncology to improve treatment options for melanoma patients. Early career radiation oncologists, radiation or cancer biologists, or a physicists are encouraged to submit radiation oncology Research Proposals that include at least 50 percent effort on melanoma.

The award will provide up to $67,000 per year for three years (up to $200,000 total) to be combined with at least $100,000 matching funds or in kind contribution from the applicant’s institution. Neither ASTRO nor MRA will pay indirect costs as part of this award.

Am I eligible?

You are eligible if:

  • You are an investigator employed by a recognized U.S. research institution (PhD, MD or MD/PhD) with no more than five years in a faculty appointment or other full-time independent research position at the time of application, and an ASTRO member in good standing.
  • Investigators must designate a mentor at the same institution who will provide guidance and support. Mentors should be senior investigators with a minimum of R01 or equivalent level funding and provide a letter of support detailing their oversight and support.
  • The project detailed in your proposal must include at least 50% effort on melanoma.
  • Other eligibility requirements as listed in the full RFP.

Your institutions's responsibilities:

  • The department or institution must provide at least $100,000 matching funds or an equivalent in-kind contribution to further support the PI and research effort. In-kind contributions can include protected time for research, access to dedicated space, core research facilities, or similar types of contributions.
  • The institution will be required to provide sufficient additional funds to supplement salaries or supplies as needed for the research.
  • Other responsibilities as listed in the full RFP.

How do I apply?

The applications will be accepted through ProposalCentral's online submission service. Paper applications are not accepted. Applications for the 2018-2019 funding cycle are now open. Before you can submit the application, the ASTRO-MRA Early Career Investigator Applicant Eligibility Checklist must be completed and returned to MRA Scientific Program Manager Tasheema Prince at tprince@curemelanoma.org by October 29, 2018. You can then apply for the grant using ProposalCentral. Applications are due on November 9, 2018. To view the full proposal, click here.

Award offered in partnership with the Melanoma Research Alliance.

We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.